Cardiovasc Hematol Agents Med Chem
September 2022
Aims: The study aimed to assess the antihypertensive activity of Calamintha officinalis.
Background: Calamintha officinalis (CO) is a medicinal and aromatic herb as well as an antihypertensive plant that is widely used for its medicinal properties in several regions.
Objective: This study aimed to evaluate the effect of the aqueous extract of Calamintha officinalis (AECO) on vasorelaxant activity and arterial blood pressure under normal and hypertensive states in rats.
Cardiovasc Hematol Disord Drug Targets
February 2022
Aims: This work assessed the antihyperglycemic effect of Euphorbia guyoniana.
Background: Euphorbia guyoniana (Boss. and Reut.
Cardiovasc Hematol Disord Drug Targets
February 2022
Aims: The aim of the study was to evaluate the antihyperglycemic activity of propolis from Saharan region of Morocco.
Background: Propolis is known from ancient times for its beneficial action on health.
Objective: The study aimed to evaluate the effect of Moroccan propolis aqueous extract from the desert region on glycemia and lipid metabolism.
Cardiovasc Hematol Agents Med Chem
June 2021
Aims: The study aimed to evaluate the antihyperlipidemic and antioxidant activities of Matricaria pubescens.
Background: Matricaria pubescens (Desf.) Shultz belongs to Asteraceae family and it is commonly used traditionally for handling diabetes mellitus.